Completed OBSERVATIONAL NCT07052708
The Impact of Medication Adherence in Patients With Type 2 Diabetes and Disabilities
Impact of Medication Adherence on Cardiovascular Outcomes in Individuals With Type 2 Diabetes and Disabilities: Nationwide Cohort Study
Sponsor: Samsung Medical Center
Conditions
Disabilities Type 2 Diabetes
Interventions
Adherence group No adherence group
Updated 1 time since 2025 Last updated: Jul 5, 2025 Started: Jan 1, 2010 Primary completion: Mar 30, 2023 Completion: Sep 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07052708, this observational or N/A phase trial focuses on Disabilities and Type 2 Diabetes and remains completed. Sponsored by Samsung Medical Center, it has been updated 1 time since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Samsung Medical Center
Data source: Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.